We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002236:SZSEZhejiang Dahua Technology Co., Ltd. Analysis

Data as of 2026-05-24 - not real-time

CN¥17.86

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Zhejiang Dahua Technology trades around CNY 17.86, comfortably above its 20‑day (CNY 18.10) and 50‑day (CNY 17.81) moving averages but still below the 200‑day average, indicating short‑term momentum with longer‑term caution. Its trailing PE of 15x is well below the industry average of ~30x, and a dividend yield of 3.1% with a 54% payout ratio suggests attractive income. However, the DCF‑derived fair value of roughly CNY 4 indicates the current price may be stretched, and a bearish MACD coupled with neutral RSI (~48) points to limited upside in the immediate term.
The company shows solid fundamentals – 10% revenue growth, healthy cash reserves (CNY 7.9 bn) versus modest debt (CNY 0.68 bn), and consistent free cash flow – but faces medium regulatory risk in China’s security‑technology sector and a beta that suggests low market volatility. Overall, investors should weigh the dividend appeal and relative valuation against the valuation gap and regulatory backdrop.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram suggests limited near‑term upside
  • Price near recent resistance level around CNY 18.86
  • Attractive dividend yield provides income while waiting for catalyst

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst target median price of CNY 22.5 implies ~27% upside
  • PE well below industry average indicating value potential
  • Steady revenue growth and strong cash generation support earnings expansion

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Long‑term dividend sustainability with moderate payout ratio
  • DCF fair value gap raises valuation concerns over extended horizon
  • Medium regulatory risk in China’s security‑tech space could affect growth

Key Metrics & Analysis

Financial Health

Revenue Growth10.30%
Profit Margin11.69%
P/E Ratio15.0
ROE10.07%
ROA3.75%
Debt/Equity1.72
P/B Ratio1.5
Op. Cash FlowCN¥3.8B
Free Cash FlowCN¥296.1M
Industry P/E29.7

Technical Analysis

TrendNeutral
RSI47.9
SupportCN¥17.40
ResistanceCN¥18.86
MA 20CN¥18.10
MA 50CN¥17.81
MA 200CN¥18.68
MACDBearish
VolumeStable
Fear & Greed Index91.61

Valuation

Fair ValueCN¥4.03
Target PriceCN¥22.83
Upside/Downside27.83%
GradeOvervalued
TypeBlend
Dividend Yield3.11%

Risk Assessment

Beta0.16
Volatility28.40%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.